Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat ...
News-Medical.Net on MSN
Antihypertensive and lipid-lowering drugs show efficacy against steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one ...
Two drugs already approved for cardiovascular conditions – pemafibrate and telmisartan – could be used in combination to help ...
Animal studies show hope of an effective and safe treatment for the chronic liver condition affecting 25 percent of US adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback